The global Cold Chain for Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Cold Chain for Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Cold Chain for Drug market. Cold Chain for Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Cold Chain for Drug. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Cold Chain for Drug market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Cold Chain for Drug market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Cold Chain for Drug market. It may include historical data, market segmentation by Type (e.g., Refrigerated Storage, Cold Chain Logistics), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Cold Chain for Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Cold Chain for Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Cold Chain for Drug industry. This include advancements in Cold Chain for Drug technology, Cold Chain for Drug new entrants, Cold Chain for Drug new investment, and other innovations that are shaping the future of Cold Chain for Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Cold Chain for Drug market. It includes factors influencing customer ' purchasing decisions, preferences for Cold Chain for Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Cold Chain for Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Cold Chain for Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Cold Chain for Drug market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Cold Chain for Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Cold Chain for Drug market.
麻豆原创 Segmentation:
Cold Chain for Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Refrigerated Storage
Cold Chain Logistics
Segmentation by application
Pharmaceutical Companies
Hospital
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AmeriCold Logistics
Nichirei Logistics Group
Lineage Logistics
OOCL Logistics
Burris Logistics
VersaCold Logistics Services
JWD Group
Swire Group
Preferred Freezer Services
Swift Transportation
AGRO Merchants Group, LLC
XPO Logistics
CWT Limited
Kloosterboer
NewCold Co枚peratief U.A.
DHL
SCG Logistics
X2 Group
AIT
Gruppo Marconi Logistica Integrata
Best Cold Chain Co.
A.B. Oxford Cold Storage
Interstate Cold Storage
Assa Abloy
Cloverleaf Cold Storage
Chase Doors
ColdEX
Crystal Logistic Cool Chain Ltd
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Cold Chain for Drug 麻豆原创 Size 2019-2030
2.1.2 Cold Chain for Drug 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Cold Chain for Drug Segment by Type
2.2.1 Refrigerated Storage
2.2.2 Cold Chain Logistics
2.3 Cold Chain for Drug 麻豆原创 Size by Type
2.3.1 Cold Chain for Drug 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Cold Chain for Drug 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Cold Chain for Drug Segment by Application
2.4.1 Pharmaceutical Companies
2.4.2 Hospital
2.4.3 Other
2.5 Cold Chain for Drug 麻豆原创 Size by Application
2.5.1 Cold Chain for Drug 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Cold Chain for Drug 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Cold Chain for Drug 麻豆原创 Size by Player
3.1 Cold Chain for Drug 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Cold Chain for Drug Revenue by Players (2019-2024)
3.1.2 Global Cold Chain for Drug Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Cold Chain for Drug Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cold Chain for Drug by Regions
4.1 Cold Chain for Drug 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Cold Chain for Drug 麻豆原创 Size Growth (2019-2024)
4.3 APAC Cold Chain for Drug 麻豆原创 Size Growth (2019-2024)
4.4 Europe Cold Chain for Drug 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Cold Chain for Drug 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Cold Chain for Drug 麻豆原创 Size by Country (2019-2024)
5.2 Americas Cold Chain for Drug 麻豆原创 Size by Type (2019-2024)
5.3 Americas Cold Chain for Drug 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cold Chain for Drug 麻豆原创 Size by Region (2019-2024)
6.2 APAC Cold Chain for Drug 麻豆原创 Size by Type (2019-2024)
6.3 APAC Cold Chain for Drug 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cold Chain for Drug by Country (2019-2024)
7.2 Europe Cold Chain for Drug 麻豆原创 Size by Type (2019-2024)
7.3 Europe Cold Chain for Drug 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cold Chain for Drug by Region (2019-2024)
8.2 Middle East & Africa Cold Chain for Drug 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Cold Chain for Drug 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Cold Chain for Drug 麻豆原创 Forecast
10.1 Global Cold Chain for Drug Forecast by Regions (2025-2030)
10.1.1 Global Cold Chain for Drug Forecast by Regions (2025-2030)
10.1.2 Americas Cold Chain for Drug Forecast
10.1.3 APAC Cold Chain for Drug Forecast
10.1.4 Europe Cold Chain for Drug Forecast
10.1.5 Middle East & Africa Cold Chain for Drug Forecast
10.2 Americas Cold Chain for Drug Forecast by Country (2025-2030)
10.2.1 United States Cold Chain for Drug 麻豆原创 Forecast
10.2.2 Canada Cold Chain for Drug 麻豆原创 Forecast
10.2.3 Mexico Cold Chain for Drug 麻豆原创 Forecast
10.2.4 Brazil Cold Chain for Drug 麻豆原创 Forecast
10.3 APAC Cold Chain for Drug Forecast by Region (2025-2030)
10.3.1 China Cold Chain for Drug 麻豆原创 Forecast
10.3.2 Japan Cold Chain for Drug 麻豆原创 Forecast
10.3.3 Korea Cold Chain for Drug 麻豆原创 Forecast
10.3.4 Southeast Asia Cold Chain for Drug 麻豆原创 Forecast
10.3.5 India Cold Chain for Drug 麻豆原创 Forecast
10.3.6 Australia Cold Chain for Drug 麻豆原创 Forecast
10.4 Europe Cold Chain for Drug Forecast by Country (2025-2030)
10.4.1 Germany Cold Chain for Drug 麻豆原创 Forecast
10.4.2 France Cold Chain for Drug 麻豆原创 Forecast
10.4.3 UK Cold Chain for Drug 麻豆原创 Forecast
10.4.4 Italy Cold Chain for Drug 麻豆原创 Forecast
10.4.5 Russia Cold Chain for Drug 麻豆原创 Forecast
10.5 Middle East & Africa Cold Chain for Drug Forecast by Region (2025-2030)
10.5.1 Egypt Cold Chain for Drug 麻豆原创 Forecast
10.5.2 South Africa Cold Chain for Drug 麻豆原创 Forecast
10.5.3 Israel Cold Chain for Drug 麻豆原创 Forecast
10.5.4 Turkey Cold Chain for Drug 麻豆原创 Forecast
10.5.5 GCC Countries Cold Chain for Drug 麻豆原创 Forecast
10.6 Global Cold Chain for Drug Forecast by Type (2025-2030)
10.7 Global Cold Chain for Drug Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 AmeriCold Logistics
11.1.1 AmeriCold Logistics Company Information
11.1.2 AmeriCold Logistics Cold Chain for Drug Product Offered
11.1.3 AmeriCold Logistics Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 AmeriCold Logistics Main Business Overview
11.1.5 AmeriCold Logistics Latest Developments
11.2 Nichirei Logistics Group
11.2.1 Nichirei Logistics Group Company Information
11.2.2 Nichirei Logistics Group Cold Chain for Drug Product Offered
11.2.3 Nichirei Logistics Group Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Nichirei Logistics Group Main Business Overview
11.2.5 Nichirei Logistics Group Latest Developments
11.3 Lineage Logistics
11.3.1 Lineage Logistics Company Information
11.3.2 Lineage Logistics Cold Chain for Drug Product Offered
11.3.3 Lineage Logistics Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Lineage Logistics Main Business Overview
11.3.5 Lineage Logistics Latest Developments
11.4 OOCL Logistics
11.4.1 OOCL Logistics Company Information
11.4.2 OOCL Logistics Cold Chain for Drug Product Offered
11.4.3 OOCL Logistics Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 OOCL Logistics Main Business Overview
11.4.5 OOCL Logistics Latest Developments
11.5 Burris Logistics
11.5.1 Burris Logistics Company Information
11.5.2 Burris Logistics Cold Chain for Drug Product Offered
11.5.3 Burris Logistics Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Burris Logistics Main Business Overview
11.5.5 Burris Logistics Latest Developments
11.6 VersaCold Logistics Services
11.6.1 VersaCold Logistics Services Company Information
11.6.2 VersaCold Logistics Services Cold Chain for Drug Product Offered
11.6.3 VersaCold Logistics Services Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 VersaCold Logistics Services Main Business Overview
11.6.5 VersaCold Logistics Services Latest Developments
11.7 JWD Group
11.7.1 JWD Group Company Information
11.7.2 JWD Group Cold Chain for Drug Product Offered
11.7.3 JWD Group Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 JWD Group Main Business Overview
11.7.5 JWD Group Latest Developments
11.8 Swire Group
11.8.1 Swire Group Company Information
11.8.2 Swire Group Cold Chain for Drug Product Offered
11.8.3 Swire Group Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Swire Group Main Business Overview
11.8.5 Swire Group Latest Developments
11.9 Preferred Freezer Services
11.9.1 Preferred Freezer Services Company Information
11.9.2 Preferred Freezer Services Cold Chain for Drug Product Offered
11.9.3 Preferred Freezer Services Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Preferred Freezer Services Main Business Overview
11.9.5 Preferred Freezer Services Latest Developments
11.10 Swift Transportation
11.10.1 Swift Transportation Company Information
11.10.2 Swift Transportation Cold Chain for Drug Product Offered
11.10.3 Swift Transportation Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Swift Transportation Main Business Overview
11.10.5 Swift Transportation Latest Developments
11.11 AGRO Merchants Group, LLC
11.11.1 AGRO Merchants Group, LLC Company Information
11.11.2 AGRO Merchants Group, LLC Cold Chain for Drug Product Offered
11.11.3 AGRO Merchants Group, LLC Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 AGRO Merchants Group, LLC Main Business Overview
11.11.5 AGRO Merchants Group, LLC Latest Developments
11.12 XPO Logistics
11.12.1 XPO Logistics Company Information
11.12.2 XPO Logistics Cold Chain for Drug Product Offered
11.12.3 XPO Logistics Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 XPO Logistics Main Business Overview
11.12.5 XPO Logistics Latest Developments
11.13 CWT Limited
11.13.1 CWT Limited Company Information
11.13.2 CWT Limited Cold Chain for Drug Product Offered
11.13.3 CWT Limited Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 CWT Limited Main Business Overview
11.13.5 CWT Limited Latest Developments
11.14 Kloosterboer
11.14.1 Kloosterboer Company Information
11.14.2 Kloosterboer Cold Chain for Drug Product Offered
11.14.3 Kloosterboer Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 Kloosterboer Main Business Overview
11.14.5 Kloosterboer Latest Developments
11.15 NewCold Co枚peratief U.A.
11.15.1 NewCold Co枚peratief U.A. Company Information
11.15.2 NewCold Co枚peratief U.A. Cold Chain for Drug Product Offered
11.15.3 NewCold Co枚peratief U.A. Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.15.4 NewCold Co枚peratief U.A. Main Business Overview
11.15.5 NewCold Co枚peratief U.A. Latest Developments
11.16 DHL
11.16.1 DHL Company Information
11.16.2 DHL Cold Chain for Drug Product Offered
11.16.3 DHL Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.16.4 DHL Main Business Overview
11.16.5 DHL Latest Developments
11.17 SCG Logistics
11.17.1 SCG Logistics Company Information
11.17.2 SCG Logistics Cold Chain for Drug Product Offered
11.17.3 SCG Logistics Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.17.4 SCG Logistics Main Business Overview
11.17.5 SCG Logistics Latest Developments
11.18 X2 Group
11.18.1 X2 Group Company Information
11.18.2 X2 Group Cold Chain for Drug Product Offered
11.18.3 X2 Group Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.18.4 X2 Group Main Business Overview
11.18.5 X2 Group Latest Developments
11.19 AIT
11.19.1 AIT Company Information
11.19.2 AIT Cold Chain for Drug Product Offered
11.19.3 AIT Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.19.4 AIT Main Business Overview
11.19.5 AIT Latest Developments
11.20 Gruppo Marconi Logistica Integrata
11.20.1 Gruppo Marconi Logistica Integrata Company Information
11.20.2 Gruppo Marconi Logistica Integrata Cold Chain for Drug Product Offered
11.20.3 Gruppo Marconi Logistica Integrata Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.20.4 Gruppo Marconi Logistica Integrata Main Business Overview
11.20.5 Gruppo Marconi Logistica Integrata Latest Developments
11.21 Best Cold Chain Co.
11.21.1 Best Cold Chain Co. Company Information
11.21.2 Best Cold Chain Co. Cold Chain for Drug Product Offered
11.21.3 Best Cold Chain Co. Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.21.4 Best Cold Chain Co. Main Business Overview
11.21.5 Best Cold Chain Co. Latest Developments
11.22 A.B. Oxford Cold Storage
11.22.1 A.B. Oxford Cold Storage Company Information
11.22.2 A.B. Oxford Cold Storage Cold Chain for Drug Product Offered
11.22.3 A.B. Oxford Cold Storage Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.22.4 A.B. Oxford Cold Storage Main Business Overview
11.22.5 A.B. Oxford Cold Storage Latest Developments
11.23 Interstate Cold Storage
11.23.1 Interstate Cold Storage Company Information
11.23.2 Interstate Cold Storage Cold Chain for Drug Product Offered
11.23.3 Interstate Cold Storage Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.23.4 Interstate Cold Storage Main Business Overview
11.23.5 Interstate Cold Storage Latest Developments
11.24 Assa Abloy
11.24.1 Assa Abloy Company Information
11.24.2 Assa Abloy Cold Chain for Drug Product Offered
11.24.3 Assa Abloy Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.24.4 Assa Abloy Main Business Overview
11.24.5 Assa Abloy Latest Developments
11.25 Cloverleaf Cold Storage
11.25.1 Cloverleaf Cold Storage Company Information
11.25.2 Cloverleaf Cold Storage Cold Chain for Drug Product Offered
11.25.3 Cloverleaf Cold Storage Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.25.4 Cloverleaf Cold Storage Main Business Overview
11.25.5 Cloverleaf Cold Storage Latest Developments
11.26 Chase Doors
11.26.1 Chase Doors Company Information
11.26.2 Chase Doors Cold Chain for Drug Product Offered
11.26.3 Chase Doors Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.26.4 Chase Doors Main Business Overview
11.26.5 Chase Doors Latest Developments
11.27 ColdEX
11.27.1 ColdEX Company Information
11.27.2 ColdEX Cold Chain for Drug Product Offered
11.27.3 ColdEX Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.27.4 ColdEX Main Business Overview
11.27.5 ColdEX Latest Developments
11.28 Crystal Logistic Cool Chain Ltd
11.28.1 Crystal Logistic Cool Chain Ltd Company Information
11.28.2 Crystal Logistic Cool Chain Ltd Cold Chain for Drug Product Offered
11.28.3 Crystal Logistic Cool Chain Ltd Cold Chain for Drug Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.28.4 Crystal Logistic Cool Chain Ltd Main Business Overview
11.28.5 Crystal Logistic Cool Chain Ltd Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
